These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2437067)
1. [Progress in the therapy of malignant tumors]. Gropp C Internist (Berl); 1987 Jan; 28(1):44-52. PubMed ID: 2437067 [No Abstract] [Full Text] [Related]
2. Immunological monitoring and clinical trials of biological response modifiers. Baseler MW; Urba WJ Cancer Chemother Biol Response Modif; 1992; 13():205-29. PubMed ID: 1382527 [No Abstract] [Full Text] [Related]
3. [Malignant hemopathies in adults and bone marrow graft]. Nöel DR Union Med Can; 1988; 117(2):157-8. PubMed ID: 3041660 [No Abstract] [Full Text] [Related]
4. [New perspectives in the treatment of cancer]. Degos L Pathol Biol (Paris); 1989 Nov; 37(9):979-80. PubMed ID: 2481837 [No Abstract] [Full Text] [Related]
5. [Interferons, interleukin-2 and tumor necrosis factor. New approaches to cancer therapy]. Oettgen HF Arzneimittelforschung; 1987 Feb; 37(2A):251-5. PubMed ID: 2436634 [TBL] [Abstract][Full Text] [Related]
6. [Intensive chemotherapy with autologous bone marrow transplantation: assessment and limits. What is its future?]. Gisselbrecht C Bull Cancer; 1995; 82 Suppl 1():51s-52s. PubMed ID: 7542944 [No Abstract] [Full Text] [Related]
7. [Cytokines and monoclonal antibodies. Immunologic approaches to tumor therapy]. Pfreundschuh M Fortschr Med; 1986 Dec; 104(47-48):973-6. PubMed ID: 2434398 [No Abstract] [Full Text] [Related]
8. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. Winkelhake JL; Stampfl S; Zimmerman RJ Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953 [TBL] [Abstract][Full Text] [Related]
10. Interleukins, interferons and tumor necrosis factor in cancer treatment. Krigel RL AAOHN J; 1987 Apr; 35(4):159-62. PubMed ID: 2950885 [No Abstract] [Full Text] [Related]
11. [The role of allogeneic bone marrow transplantation in patients with acute leukemia during first remission]. Takemoto Y; Shinohara Y; Fujimori Y; Andoh S; Akagi T; Okuda K; Okada Y; Kobaba R; Sawada C; Inoue N Rinsho Ketsueki; 1988 Nov; 29(11):2018-23. PubMed ID: 3070072 [No Abstract] [Full Text] [Related]
12. [The value of bone marrow transplantation in the treatment of leukemia]. Ehninger G; Schuler U; Haas R Internist (Berl); 1993 Jun; 34(6):550-7. PubMed ID: 8101514 [No Abstract] [Full Text] [Related]
13. [Chemotherapy of malignant melanoma]. Avril MF Ann Dermatol Venereol; 1988; 115(9):959-68. PubMed ID: 2464963 [No Abstract] [Full Text] [Related]
14. [Cancer of the kidney in adults. Treatment of the metastatic stage]. Prog Urol; 1997 Nov; 7(5):879-95. PubMed ID: 9458484 [No Abstract] [Full Text] [Related]
15. [Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma]. Wörmann B; Unterhalt M; Hiddemann W Internist (Berl); 1993 Feb; 34(2):132-8. PubMed ID: 8454426 [No Abstract] [Full Text] [Related]
16. [Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor]. Endo M; Tanosaki R Gan To Kagaku Ryoho; 1995 Oct; 22(12):1762-70. PubMed ID: 7574807 [TBL] [Abstract][Full Text] [Related]
17. [The importance of the autologous bone marrow transplant in the treatment of solid tumors]. Aramburo González P Rev Clin Esp; 1994 Nov; 194(11):949-52. PubMed ID: 7846350 [No Abstract] [Full Text] [Related]
18. Current trials in acute leukaemia. Nagesh K; Jowitt SN; Scarffe JH Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):532-6. PubMed ID: 8958408 [No Abstract] [Full Text] [Related]